Direct-acting antiviral agents

Direct-acting antiviral agents (DAAs) are medications used to treat hepatitis C by specifically targeting the virus’s ability to replicate. They work by blocking enzymes or proteins essential for the virus’s life cycle, which helps stop the infection from spreading and allows the immune system to clear it. DAAs are highly effective, have fewer side effects than older treatments, and can often cure hepatitis C in a few months. They represent a significant advancement in managing the disease, providing hope for many patients to achieve long-term health.